Procept Biorobotics Corp reports results for the quarter ended December 31 - Earnings Summary

• Procept Biorobotics Corp PRCT.OQ reported a quarterly adjusted loss of 35 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -54 cents. The mean expectation of nine analysts for the quarter was for a loss of 33 cents per share. Wall Street expected results to range from -35 cents to -29 cents per share.

• Revenue rose 56.6% to $68.24 million from a year ago; analysts expected $66.78 million.

• Procept Biorobotics Corp's reported EPS for the quarter was a loss of 35 cents​.

• The company reported a quarterly loss of $18.86 million.

• Procept Biorobotics Corp shares had fallen by 19.1% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Procept Biorobotics Corp is $103.00

This summary was machine generated from LSEG data February 25 at 10:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)